Phase I Nicotinic Agonist Treatment Trial for Autism

Trial Profile

Phase I Nicotinic Agonist Treatment Trial for Autism

Phase of Trial: Phase I

Latest Information Update: 20 Jun 2016

At a glance

  • Drugs GTS 21 (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jun 2016 Status changed from recruiting to discontinued due to reasons like difficult to find participants and no funding.
    • 09 Jun 2015 Status changed from not yet recruiting to recruiting as reported by
    • 03 Dec 2014 Planned initiation date changed from 1 Aug 2014 to 1 Aug 2015 as reported by record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top